Section Arrow
DCTH.NASDAQ
- Delcath Systems
Quotes are at least 15-min delayed:2024/09/28 12:45 EDT
Last
 9.135
+0.265 (+2.99%)
Day High 
9.23 
Prev. Close
8.87 
1-M High
11.745 
Volume 
202.95K 
Bid
9.13
Ask
9.29
Day Low
8.8832 
Open
9.01 
1-M Low
8.72 
Market Cap 
248.37M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 9.11 
20-SMA 9.69 
50-SMA 8.83 
52-W High 11.745 
52-W Low 2.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.52/0.09
Enterprise Value
256.21M
Balance Sheet
Book Value Per Share
0.15
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.07M
Operating Revenue Per Share
0.09
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
VEROVenus Concept0.71+0.1231+20.97%-- 
MDTMedtronic plc89.32+0.57+0.64%30.12PE
EWEdwards Lifesciences Corp66.58+0.81+1.23%25.89PE
BSXBoston Scientific Corp83.35+0.27+0.32%67.54PE
PACBPacific Biosciences of California1.75+0.01+0.57%-- 
Quotes are at least 15-min delayed:2024/09/28 12:45 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS,is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.